Veranex, a global provider of product development and contract research services, today introduced the industry’s first ...

Johnson & Johnson raised its full-year sales forecast on Wednesday after beating estimates for second-quarter profit on ...

Johnson & Johnson (NYSE:JNJ) is set to kick off the second quarter pharma earnings on Wednesday, with investors focusing on ...

Johnson & Johnson (NYSE: JNJ) shares ticked up before hours today on second-quarter results that came in ahead of the ...

Three young Triangle-based medical technology companies with roots in Duke University research labs are getting major global attention from their industry. They’re among the 65 cutting-edge companies ...

Reviewing its MedTech coverage ahead of the Q2 earnings season on Tuesday, Morgan Stanley upgraded Steris (NYSE:STE) and Solventum (NYSE:SOLV) to Overweight from Equal Weight and downgraded RxSight ...

The year kicked off with a handful of acquisitions from top companies. Dealmaking has since slowed amid economic uncertainty ...

Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, ...

Johnson & Johnson MedTech today announced FDA approval for an update to its Varipulse platform's irrigation flow rate.

Proximie (the "Company"), the leading global health technology platform digitising operating rooms ("OR"), announces a ...

One Six 8 Ventures’ Judyanna Yu explains why capital alone isn’t enough to scale life sciences companies at home.

Medical technology has been on the up for many years, and professionals and experts in Australia have been making strides in innovation over the last decade.